Verilopam is primarily explored for its potential therapeutic applications in the field of neurology and psychiatry. It acts as a selective ligand for certain receptors in the brain, making it a candidate for the treatment of neurological disorders. Research has focused on its efficacy in managing conditions such as anxiety, depression, and chronic pain, where modulation of receptor activity can provide symptomatic relief. Additionally, its pharmacological profile suggests it may have a role in addressing substance abuse disorders by influencing reward pathways in the brain. Clinical studies are ongoing to further evaluate its safety, efficacy, and potential as a novel therapeutic agent.